Economic Burden of Diabetes Mellitus in Urban Population of Pakistan: A Cross-Sectional Analysis of Direct and Indirect Costs
A Quantitative Assessment of Treatment Expenses and Productivity Losses
DOI:
https://doi.org/10.63516/Keywords:
diabetes mellitus, economic burden, urban Pakistan, healthcare costs, catastrophic health expenditureAbstract
Background: Diabetes mellitus represents a rapidly growing public health challenge in Pakistan, with urban populations experiencing particularly high prevalence rates. The economic burden on individuals, families, and healthcare systems remains inadequately quantified, limiting evidence-based policy formulation. To comprehensively assess the direct and indirect economic costs associated with diabetes mellitus among urban populations in Pakistan.
Methods: A cross-sectional analysis was conducted across major healthcare facilities in Islamabad and Karachi involving 1,324 diagnosed diabetic patients recruited through systematic sampling. Direct costs included medical expenses (consultations, medications, laboratory tests, hospitalizations), while indirect costs encompassed productivity losses, transportation expenses, and caregiver time. Data collection utilized structured questionnaires, medical record reviews, and three-month cost diaries. Economic analysis was conducted from healthcare system and societal perspectives.
Results: Mean annual direct medical costs were PKR 89,750 per patient in Islamabad and PKR 76,340 in Karachi. Total annual costs including indirect expenses reached PKR 156,890 and PKR 134,220 respectively. Medications constituted 43.2% of direct costs, followed by monitoring and consultations (28.7%). Catastrophic health expenditure affected 52.8% of families in Islamabad and 58.3% in Karachi. Type 2 diabetes patients with complications incurred 2.3 times higher costs than those without complications. Lower-income families spent proportionally more household income on diabetes management (18.4% vs. 7.2%).
Conclusion: Diabetes mellitus imposes significant economic burden on urban Pakistani populations, with substantial costs disproportionately affecting lower-income families. High catastrophic health expenditure prevalence indicates inadequate financial protection mechanisms. Findings highlight urgent needs for comprehensive prevention programs, improved healthcare financing, and enhanced primary care services.
References
1. Ahmad, F., & Anwar, S. (2023). Socio economic factors associated with prevalence of non-communicable diseases among adults in Punjab, Pakistan. Annals of Punjab Medical College, 17(3), 275-280.
2. Ahmed, A., Saqlain, M., Tanveer, M., Blebil, A. Q., Dujaili, J. A., & Hasan, S. S. (2021). The impact of clinical pharmacist services on patient health outcomes in Pakistan: a systematic review. BMC health services research, 21, 1-14.
3. Arshad, M. S., Alqahtani, F., & Rasool, M. F. (2024, September). The Economic Burden of Type 2 Diabetes Mellitus in Pakistan: A Cost of Illness Study. In Healthcare (Vol. 12, No. 18, p. 1826). MDPI.
4. Azeem, S., Khan, U., & Liaquat, A. (2022). The increasing rate of diabetes in Pakistan: A silent killer. Annals of medicine and surgery, 79.
5. Bhutta, Z. A., Haq, Z. U., & Basit, A. (2022). Diabetes in Pakistan: addressing the crisis. The Lancet Diabetes & Endocrinology, 10(5), 309-310.
6. Bukhsh, A., Khan, T. M., Phisalprapa, P., Duangjai, A., Saokaew, S., Nawaz, M. S., ... & Goh, B. H. (2022). Impact of pharmacist-led diabetes self-care education on patients with type 2 diabetes in Pakistan: a randomized controlled trial. Frontiers in pharmacology, 13, 754999.
7. Butt, M. D., Ong, S. C., Wahab, M. U., Rasool, M. F., Saleem, F., Hashmi, A., ... & Babar, Z. U. D. (2022). Cost of illness analysis of type 2 diabetes mellitus: the findings from a lower-middle income country. International Journal of Environmental Research and Public Health, 19(19), 12611.
8. Butt, M. D., Ong, S. C., Rafiq, A., Kalam, M. N., Sajjad, A., Abdullah, M., ... & Babar, Z. U. D. (2024). A systematic review of the economic burden of diabetes mellitus: contrasting perspectives from high and low middle-income countries. Journal of pharmaceutical policy and practice, 17(1), 2322107.
9. Eze, P., Ilechukwu, S., & Lawani, L. O. (2023). Impact of community-based health insurance in low-and middle-income countries: a systematic review and meta-analysis. PLoS One, 18(6), e0287600.
10. Haig, M., Therianos, P., Miracolo, A., Satish, K., & Kanavos, P. (2025). The burden of diabetes and options for reform: insights for the Greek health system.
11. Jalilian, H., Heydari, S., Imani, A., Salimi, M., Mir, N., & Najafipour, F. (2023). Economic burden of type 2 diabetes in Iran: A cost‐of‐illness study. Health Science Reports, 6(2), e1120.
12. Jokhio, A. H., Talpur, K. I., Shujaat, S., Talpur, B. R., & Memon, S. (2022). Prevalence of diabetic retinopathy in rural Pakistan: A population based cross-sectional study. Indian Journal of Ophthalmology, 70(12), 4364-4369.
13. Kazmi, T., Nagi, M. L. F., Razzaq, S., Hussnain, S., Shahid, N., & Athar, U. (2022). Burden of noncommunicable diseases in Pakistan. Eastern Mediterranean Health Journal, 28(11), 798-804.
14. Khalid, F., Raza, W., Hotchkiss, D. R., & Soelaeman, R. H. (2021). Health services utilization and out-of-pocket (OOP) expenditures in public and private facilities in Pakistan: an empirical analysis of the 2013–14 OOP health expenditure survey. BMC health services research, 21, 1-14.
15. Kristina, S. A., Endarti, D. W. I., ANDAYANI, T. M., & WIDAYANTI, A. W. (2021). Direct and Indirect Cost of Diabetes Mellitus in Indonesia: A Prevalence Based Study with Human Capital Approach. International Journal of Pharmaceutical Research (09752366), 13(1).
16. Mir, K., & Ayyub, H. (2021). Prices, availability and affordability of essential medicines for non-communicable diseases: a facility based survey in district Abbotabad: availability and affordability of essential medicines for non-communicable diseases. Pakistan BioMedical Journal, 4(2), 97-102.
17. Mseke, E. P., Jessup, B., & Barnett, T. (2024). Impact of distance and/or travel time on healthcare service access in rural and remote areas: A scoping review. Journal of Transport & Health, 37, 101819.
18. Mustafa, K., Nosheen, M., & Khan, A. U. (2021). Dynamic reflections of multidimensional health poverty in Pakistan. PloS One, 16(11), e0258947.
19. Nadeem, S., Siddiqi, U., Martins, R. S., & Badini, K. (2021). Perceptions and understanding of diabetes mellitus technology in adults with type 1 or type 2 DM: A pilot survey from Pakistan. Journal of Diabetes Science and Technology, 15(5), 1052-1058.
20. Nasim, S., Mahmood, A., Said, F., & Suhail, J. (2022) The path to a successful pakistan.
21. O’Keef, P., & Haldane, V. (2024). Towards a Framework for impact pathways between NCDS, Human Capital and Healthy Longevity, Economic and Wellbeing Outcomes (No. 42144). The World Bank Group.
22. Parker, E. D., Lin, J., Mahoney, T., Ume, N., Yang, G., Gabbay, R. A., ... & Bannuru, R. R. (2024). Economic costs of diabetes in the US in 2022. Diabetes care, 47(1), 26-43.
23. Raadabadi, M., Daroudi, R., Zendehdel, K., Haghdoost, A. A., Ebadzadeh, M. R., & Rashidian, H. (2023). Direct and indirect medical costs of bladder cancer in Iran. Cost Effectiveness and Resource Allocation, 21(1), 5.
24. Shaikh, B. T. (2024). Universal health coverage in Pakistan: exploring the landscape of the health system, health seeking behaviours, and utilization of health services. The Lancet Regional Health-Southeast Asia, 27.
25. World Health Organization. (2022). Global report on health equity for persons with disabilities. World Health Organization.
26. World Health Organization. (2021). Global monitoring report on financial protection in health 2021. World Health Organization.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Archives of Management and Social Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
